A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves’ patients undergoing antithyroid drug (ATD) treatment - Giuliani, C; Cerrone, D; Harii, N (J Clin Endocrinol Metab, 2012)
et al.